Sertraline- and mirtazapine-induced severe neutropenia.
Ozcanli
Tuba
T
Unsalver
Baris
B
Ozdemir
Samuray
S
Ozmen
Mine
M
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D009503:Neutropenia / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use*; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline